Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03962634 · ClinicalTrials.gov registry record · Phase 2
Kovanaze Vs. Articaine in Achieving Pulpal Anesthesia of Maxillary Teeth - Pediatric
A Phase 2 study, sponsored by Virginia Commonwealth University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT03962634 is a Phase 2 study that was terminated before completion, run by Virginia Commonwealth University. The registered enrollment target is 3 participants.
The verdict
NCT03962634, a Phase 2 study, was terminated before completion, sponsored by Virginia Commonwealth University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
The primary goal of the study is to compare the success rates of pulpal anesthesia (defined as ability to complete the intended dental procedure without the need for rescue anesthesia) between Kovanaze nasal mist and Articaine needle anesthesia.
Interventions
- DRUG Kovanaze Nasal Spray
- DRUG Articaine Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2019-08-28 |
| Est. Completion | 2019-09-17 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03962634
The ClinicalTrials.gov registry entry for NCT03962634 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Kovanaze Nasal Spray is the first listed.
NCT03962634 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03962634 about?
NCT03962634 is a clinical study titled "Kovanaze Vs. Articaine in Achieving Pulpal Anesthesia of Maxillary Teeth - Pediatric". The primary goal of the study is to compare the success rates of pulpal anesthesia (defined as ability to complete the intended dental procedure without the need for rescue anesthesia) between Kovanaze nasal mist and Articaine needle anesthesia.
What is the current status of trial NCT03962634?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2019-08-28. Estimated completion is 2019-09-17.
What interventions are being tested in trial NCT03962634?
The interventions under investigation include: Kovanaze Nasal Spray (DRUG), Articaine Injection (DRUG).
Who is sponsoring clinical trial NCT03962634?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.